awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37316259-B5BD18AF-C8C6-4A92-B758-33780E281A4B
Q37316259-B5BD18AF-C8C6-4A92-B758-33780E281A4B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37316259-B5BD18AF-C8C6-4A92-B758-33780E281A4B
Incretin-based therapies: new treatments for type 2 diabetes in the new millennium.
P2860
Q37316259-B5BD18AF-C8C6-4A92-B758-33780E281A4B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37316259-B5BD18AF-C8C6-4A92-B758-33780E281A4B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7f188aa8926235b4e26364b538b3e8fef306f5f4
P2860
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes and inadequate glycemic control: a randomized, double-blind, placebo-controlled study